Alzheimer Disease
Neur-Hitech signs agreement with Xel to develop Alzheimer transdermal patch treatment
Published in Pain and Central Nervous System Week, April 17th, 2006
The therapeutic agent is Huperzine A, a molecule currently undergoing U.S. phase II clinical testing as an orally administered treatment for mild-to-moderate Alzheimer disease.
Reuben Seltzer, president and CEO of Neur-Hitech, said, "We are very excited by this agreement, especially so because Xel has two world renowned scientist Dr. Dinesh Patel and Dr. Danyi Quan both pioneers in transdermal patch technology, both founders and driving forces behind Xel's transdermal...
This article not available for purchase.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
More Articles from Pain and Central Nervous System Week
- Diabetes & Alzheimer Disease
Type 2 diabetes mellitus may influence outcome of concurrent late-onset Alzheimer disease - Multiple Sclerosis
Hopes raised for effectiveness of daclizumab for multiple sclerosis - Spinal Cord Injury
Combined nerve graft and growth factor treatment facilitates catecholaminergic fiber regrowth - Stem Cell Research
Stem cell treatment succeeds in spinal cord-injured rats - Stroke
Harmful enzymes may be key to stroke recovery - Adolescent Health
Poll studies the science and consequences of lost sleep in teens - More from this issue of Pain and Central Nervous System Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
